Results 51 to 60 of about 1,880,493 (302)
Çukurova Üniversitesi Tıp Fakültesi Dergisi, 2013 Purpose: To examine the difference in terms of prenatal and perinatal characteristics between gestational diabetic (GDM) cases diagnosed with impaired fasting glucose (IFG)and impaired glucose tolerance (IGT) during early postpartum period.
Okan Bakiner +4 more
doaj
Frontiers in Endocrinology, 2021 ObjectiveThe purpose of this study was to observe the relationship between impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and bone mineral density (BMD) in different sites in adolescents.MethodsA retrospective study was conducted on ...
Chun-Ming Ma, Fu-Zai Yin
doaj +1 more source
, 2015 RFG = repeat fasting glucose, IGT = impaired glucose tolerance, IFG = impaired fasting glucose, OGTT = oral glucose tolerance test. *Participants were not deemed to have completed screening if they did not return for required OGTT/RFG (n = 322) or did ...
Gerard Boran (724070) +9 more
core +1 more source
RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.
Zhimei Liu +21 more
wiley +1 more source
FREQUENCY OF IMPAIRED GLUCOSE TOLERANCE IN DIFFERENT GRADES OF OBESITY
Journal of University Medical & Dental College, 2020 Introduction Impaired glucose tolerance (IGT) is a pre-diabetic condition. It is defined as fasting glucose less than 7.0 mmol/l (25 were selected for this study.
Khalid Amin, Amin Anjum
doaj
, 2016 Comparison of characteristics between women with an impaired fasting glucose (IFG) and women with an impaired glucose tolerance (IGT) postpartum.
Roland Devlieger (669006) +4 more
core +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Frequency of Patients with Normal Glucose Tolerance or Impaired Glucose Tolerance.
, 2013 Normal Glucose Tolerance: 2h-PG≤140 mg/dl; Impaired Glucose Tolerance: 2h-PG≥140 mg/dl.OSAS, Obstructive sleep apnea syndrome; RLS, Restless legs syndrome; INS, Insomnia; CON, controls.χ2 (3) = 7.95 ...
Thomas Pollmächer (366652) +8 more
core +1 more source
Predicting Metabolic Syndrome in Obese Children and Adolescents: Look, Measure and Ask
Obesity Facts, 2013 Objective: To verify in obese children whether or not the presence of i) high waist-to-height ratio (WHtR), ii) family history for type 2 diabetes (T2D) and iii) acanthosis nigricans (AN), singularly or together, might predict the occurrence of metabolic
Nicola Santoro +8 more
doaj +1 more source
Biodegradable Conductors for Implantable and Wearable Transient Bioelectronics
Advanced Functional Materials, EarlyView.Biodegradable conductors are essential building blocks for transient bioelectronics, enabling temporary sensing, stimulation, and energy transfer while eliminating the need for device retrieval. This review summarizes biodegradable metals, conducting polymers, ionic conductors, and conductive composites, highlighting degradation mechanisms, material ...
Yicheng Zhu, Yijun Liu, Naoji Matsuhisa
wiley +1 more source